Biopsy Needle Market Report 2025

The biopsy needle market size has grown strongly in recent years. It will grow from $1.3 billion in 2024 to $1.41 billion in 2025 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to the rising demand for minimally invasive procedures, growing awareness of early diagnosis, the increasing geriatric population, greater adoption of image-guided biopsy techniques, and the heightened need for early and accurate diagnostic results.

The biopsy needle market size is expected to see strong growth in the next few years. It will grow to $1.91 billion in 2029 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to the rising demand for advanced diagnostic tools, the increasing number of screening programs, the expansion of the private healthcare sector in emerging economies, greater availability of biopsy procedures, and a growing emphasis on patient safety. Key trends expected during the forecast period include advancements in needle design and precision, innovations in imaging technologies for biopsy guidance, integration of robotic-assisted biopsy systems, real-time data monitoring during procedures, and development of disposable biopsy needles to enhance infection control.

The increasing demand for minimally invasive procedures is expected to propel the growth of the biopsy needle market going forward. Minimally invasive procedures involve medical interventions performed through small incisions or openings, reducing patient trauma and shortening recovery times. The demand for these procedures is rising due to their advantages, including faster recovery, lower risk of complications, reduced pain, and minimal scarring, making them more appealing to patients seeking safer and quicker treatment options. Biopsy needles support minimally invasive procedures by enabling precise tissue sampling, reducing the need for extensive surgical intervention, and facilitating faster diagnoses. For instance, in November 2024, according to the American Society of Plastic Surgeons, a US-based non-profit organization, the total number of cosmetic minimally invasive procedures reached 25,442,640 in 2023, marking a 7% increase from 23,672,269 in 2022. Therefore, the increasing demand for minimally invasive procedures is driving the growth of the biopsy needle market.

Companies operating in the biopsy needle market are focusing on developing technologically advanced products, such as semi-automatic core biopsy instruments, to improve precision and ease of tissue sampling in minimally invasive procedures. Semi-automatic core biopsy instruments are medical devices that use a spring-loaded mechanism to quickly and accurately collect tissue samples with minimal manual effort. For instance, in May 2023, Argon Medical Devices Inc., a US-based medical device manufacturer, launched the SuperCore Advantage semi-automatic biopsy instrument. This disposable core biopsy needle provides consistent, high-quality tissue samples for accurate diagnosis. It features an ergonomic design, a sharp cutting edge for clean specimen retrieval, and an adjustable throw length to accommodate different lesion depths. The device enhances biopsy precision while minimizing patient discomfort, offering improved diagnostic capabilities.

In October 2022, Halma plc, a UK-based technology company, acquired IZI Medical Products LLC for \$153.5 million (£138 million). Through this acquisition, Halma plc aims to strengthen its healthcare sector by expanding its portfolio of medical devices used in minimally invasive, image-guided procedures. IZI Medical Products LLC is a US-based medical device company offering a range of biopsy needles for soft tissue, bone, breast, and cranial procedures.

Major players in the biopsy needle market are Cardinal Health Inc., Medtronic plc, Becton, Dickinson and Company, Stryker Corporation, Boston Scientific Corporation, Olympus Corporation, Hologic Inc., Cook Medical, Halma plc, Merit Medical Systems Inc., ConMed Corporation, Devicor Medical Products Inc., Shandong Weigao Group Medical Polymer Company Limited, Remington Medical Inc., Advin Health Care, Nikotech Healthcare Pvt. Ltd., Argon Medical Devices Inc., Geotek Medical Products Co. Ltd., Biomedical Srl, Hakko Co. Ltd., INRAD Inc.

North America was the largest region in the biopsy needle market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in biopsy needle market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the biopsy needle market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

A biopsy needle is a specialized medical device used to extract tissue samples from the body for diagnostic examination, often under imaging guidance. It is commonly employed to detect cancer, infections, or other abnormalities in organs and tissues. The primary purpose of a biopsy needle is to obtain a minimally invasive, precise sample for histopathological analysis.

The key types of biopsy needles include disposable and non-disposable needles. A disposable biopsy needle is a single-use device designed to collect tissue samples for diagnostic purposes and is discarded after one procedure to prevent cross-contamination. These devices include needle-based biopsy guns, vacuum-assisted biopsy systems, fine needle aspiration biopsy devices, and core needle biopsy instruments, used in both image-guided and non-image-guided procedures. They are applied in diagnosing cancers or tumors of the breast, lung, prostate, colon, stomach, liver, rectum, cervix uteri, and other organs. Key end users include hospitals and surgical centers, diagnostic clinics and pathology laboratories, ambulatory care centers, and research and academic institutes.

The biopsy needle market research report is one of a series of new reports that provides biopsy needle market statistics, including biopsy needle industry global market size, regional shares, competitors with a biopsy needle market share, detailed biopsy needle market segments, market trends and opportunities, and any further data you may need to thrive in the biopsy needle industry. This biopsy needle market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The biopsy needle market consists of sales of core needle biopsy devices, Menghini needles, and Francine needles. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.